Immunovant Inc (IMVT) financials · $2.90B cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Immunovant Inc (IMVT) $2.90B cap.
| Line | FY2026 | FY2025 |
|---|---|---|
| Net Income | -$505.6M | -$413.8M |
| EPS (Diluted) | -$2.77 | -$2.73 |
| Line | FY2026 | FY2025 |
|---|---|---|
| Total Assets | $957.0M | $776.2M |
| Current Assets | $948.8M | $767.7M |
| Cash & Equivalents | $902.1M | $714.0M |
| PP&E | $443.0K | $844.0K |
| Total Liabilities | $104.4M | $68.8M |
| Current Liabilities | $104.4M | $68.8M |
| Shareholders' Equity | $852.6M | $707.4M |
| Retained Earnings | -$1.75B | -$1.24B |
| Line | FY2026 | FY2025 |
|---|---|---|
| Operating Cash Flow | -$407.3M | -$375.9M |
| CapEx | $8.00K | $759.0K |
| Investing Cash Flow | -$8.00K | -$759.0K |
| Financing Cash Flow | $595.8M | $454.5M |
| Net Change in Cash | $188.1M | $78.6M |
| Free Cash Flow | -$407.3M | -$376.6M |
FAQ
What is IMVT P/E and revenue?
Immunovant Inc (IMVT) $2.90B cap.
What is IMVT revenue?
IMVT income-statement cache has no revenue figure yet.
Is IMVT profitable?
Immunovant Inc last cached net income is -$505.6M (FY2026).
What are IMVT total assets?
Immunovant Inc last cached total assets are $957.0M (FY2026).
What is IMVT free cash flow?
Immunovant Inc last cached free cash flow is -$407.3M (FY2026).
Not investment advice. Cached statements, not a live tape.